These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14691195)

  • 1. Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction.
    Yang F; Yang XP; Liu YH; Xu J; Cingolani O; Rhaleb NE; Carretero OA
    Hypertension; 2004 Feb; 43(2):229-36. PubMed ID: 14691195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
    Rasoul S; Carretero OA; Peng H; Cavasin MA; Zhuo J; Sanchez-Mendoza A; Brigstock DR; Rhaleb NE
    J Hypertens; 2004 Mar; 22(3):593-603. PubMed ID: 15076166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats.
    Peng H; Carretero OA; Raij L; Yang F; Kapke A; Rhaleb NE
    Hypertension; 2001 Feb; 37(2 Pt 2):794-800. PubMed ID: 11230375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension.
    Peng H; Carretero OA; Brigstock DR; Oja-Tebbe N; Rhaleb NE
    Hypertension; 2003 Dec; 42(6):1164-70. PubMed ID: 14581293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Castoldi G; di Gioia CR; Bombardi C; Perego C; Perego L; Mancini M; Leopizzi M; Corradi B; Perlini S; Zerbini G; Stella A
    Clin Sci (Lond); 2009 Oct; 118(3):211-20. PubMed ID: 20310083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension.
    Rhaleb NE; Peng H; Yang XP; Liu YH; Mehta D; Ezan E; Carretero OA
    Circulation; 2001 Jun; 103(25):3136-41. PubMed ID: 11425781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research.
    Liao TD; Yang XP; D'Ambrosio M; Zhang Y; Rhaleb NE; Carretero OA
    Hypertension; 2010 Feb; 55(2):459-67. PubMed ID: 20026760
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Peng H; Xu J; Yang XP; Kassem KM; Rhaleb IA; Peterson E; Rhaleb NE
    Can J Physiol Pharmacol; 2019 Aug; 97(8):753-765. PubMed ID: 30998852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased endogenous levels of Ac-SDKP promote organ fibrosis.
    Cavasin MA; Liao TD; Yang XP; Yang JJ; Carretero OA
    Hypertension; 2007 Jul; 50(1):130-6. PubMed ID: 17470726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors: a new mechanism of action.
    Peng H; Carretero OA; Vuljaj N; Liao TD; Motivala A; Peterson EL; Rhaleb NE
    Circulation; 2005 Oct; 112(16):2436-45. PubMed ID: 16216963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.
    Cingolani OH; Yang XP; Liu YH; Villanueva M; Rhaleb NE; Carretero OA
    Hypertension; 2004 May; 43(5):1067-73. PubMed ID: 15023934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats.
    Nakagawa P; Liu Y; Liao TD; Chen X; González GE; Bobbitt KR; Smolarek D; Peterson EL; Kedl R; Yang XP; Rhaleb NE; Carretero OA
    Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1114-27. PubMed ID: 22923621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
    González GE; Rhaleb NE; Nakagawa P; Liao TD; Liu Y; Leung P; Dai X; Yang XP; Carretero OA
    Clin Sci (Lond); 2014 Jan; 126(1):85-94. PubMed ID: 23834332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
    Gao X; Xu H; Zhang B; Tao T; Liu Y; Xu D; Cai W; Wei Z; Li S; Zhang H; Mao N; Zhang G; Li D; Jin F; Li S; Zhang L; Liu H; Hao X; Yang F
    Exp Physiol; 2019 Oct; 104(10):1562-1574. PubMed ID: 31290182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
    Lin CX; Rhaleb NE; Yang XP; Liao TD; D'Ambrosio MA; Carretero OA
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1253-H1261. PubMed ID: 18641275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA
    Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
    Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X
    Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the antifibrotic potential of N-acetyl seryl-aspartyl-lysyl-proline sequence peptides.
    Ramasamy V; Ntsekhe M; Sturrock E
    Clin Exp Pharmacol Physiol; 2021 Nov; 48(11):1558-1565. PubMed ID: 34347311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.